CM512
CM512 is a biological therapy with 6 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
5
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
1 of 1 finished
0.0%
0 ended early
2
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis （NEZHA-2）
A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis.
Study of CM512 in Healthy Subjects and Patients With Atopic Dermatitis
Study of CM512 in Patients With Moderate-to-Severe Atopic Dermatitis
A Study of CM512 in Subjects With Moderate-to-Severe Chronic Obstructive Pulmonary Disease
Clinical Trials (6)
A Study of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis （NEZHA-2）
A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis.
Study of CM512 in Healthy Subjects and Patients With Atopic Dermatitis
Study of CM512 in Patients With Moderate-to-Severe Atopic Dermatitis
A Study of CM512 in Subjects With Moderate-to-Severe Chronic Obstructive Pulmonary Disease
A Study of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis （NEZHA-1）
All 6 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 6